Pre-Market Animal Food Ingredient Review Programs; Request for Comments, 65363-65364 [2024-17779]

Agencies

• Food and Drug Administration
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 89, Number 154 (Friday, August 9, 2024)]
[Notices]
[Pages 65363-65364]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-17779]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2024-N-2979]


Pre-Market Animal Food Ingredient Review Programs; Request for 
Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, we, or Agency) is 
soliciting comments from the public regarding the Food Additive 
Petition and Generally Recognized as Safe (GRAS) Notification programs 
to determine if changes are needed to promote their efficiency. 
Specific questions and information requests are included in this notice 
to help guide input from stakeholders and other members of the public.

DATES: Submit either electronic or written comments on the notice by 
December 9, 2024.

ADDRESSES: You may submit comments as follows. Please note that late, 
untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until 
11:59 p.m. Eastern Time at the end of December 9, 2024. Comments 
received by mail/hand delivery/courier (for written/paper submissions) 
will be considered timely if they are received on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to https://www.regulations.gov 
will be posted to the docket unchanged. Because your comment will be 
made public, you are solely responsible for ensuring that your comment 
does not include any confidential information that you or a third party 
may not wish to be posted, such as medical information, your or anyone 
else's Social Security number, or confidential business information, 
such as a manufacturing process. Please note that if you include your 
name, contact information, or other information that identifies you in 
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the manner 
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper 
submissions): Dockets Management Staff (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets 
Management Staff, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2024-N-2979 for ``Pre-Market Animal Food Ingredient Review 
Programs, Request for Comments.'' Received comments, those filed in a 
timely manner (see ADDRESSES), will be placed in the docket and, except 
for those submitted as ``Confidential Submissions,'' publicly viewable 
at https://www.regulations.gov or at the Dockets Management Staff 
between 9 a.m. and 4 p.m., Monday through Friday, 240-402-7500.
     Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will 
review this copy, including the claimed confidential information, in 
its consideration of comments. The second copy, which will have the 
claimed confidential information redacted/blacked out, will be 
available for public viewing and posted on https://www.regulations.gov. 
Submit both copies to the Dockets Management Staff. If you do not wish 
your name and contact information to be made publicly available, you 
can provide this information on the cover sheet and not in the body of 
your comments and you must identify this information as 
``confidential.'' Any information marked as ``confidential'' will not 
be disclosed except in accordance with 21 CFR 10.20 and other 
applicable disclosure law. For more information about FDA's posting of 
comments to public dockets, see 80 FR 56469, September 18, 2015, or 
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20852, 240-402-7500.

[[Page 65364]]


FOR FURTHER INFORMATION CONTACT: Charlotte Conway, Center for 
Veterinary Medicine, Food and Drug Administration, 7500 Standish Pl., 
Rockville, MD 20855, 240-402-6768, [email protected].

SUPPLEMENTARY INFORMATION:

I. Background

    The Federal Food, Drug, and Cosmetic Act (FD&C Act) gives FDA the 
authority to regulate substances used in animal food. Section 201(s) of 
the FD&C Act (21 U.S.C. 321(s)) defines a food additive, in part, as 
any substance whose intended use results or may reasonably be expected 
to result, directly or indirectly, in it becoming a component or 
otherwise affecting the characteristics of any food . . . if such 
substance is not generally recognized, among experts qualified by 
scientific training and experience to evaluate its safety . . . to be 
safe under the conditions of its intended use. Substances that are 
``generally recognized as safe'' (GRAS) \1\ for their intended uses in 
food are not food additives.
---------------------------------------------------------------------------

    \1\ See 21 CFR part 570, subpart E.
---------------------------------------------------------------------------

    Section 409(b) of the FD&C Act (21 U.S.C. 348(b)) and FDA's 
implementing regulations at title 21 of the Code of Federal Regulations 
(21 CFR) part 571 describe the animal food additive petition process 
and the data and information that must be submitted to FDA as part of 
an animal food additive petition to support premarket approval. In 
general, to be legally marketed and used, a food additive must be 
approved, covered by an FDA regulation, and used as described in the 
FDA regulation. Otherwise, the food additive is considered unsafe under 
section 409(a)(2) of the FD&C Act, and the food additive and any food 
that bears or contains it is adulterated under section 402(a)(2)(C)(i) 
of the FD&C Act. Approved food additives for animal food use are found 
in 21 CFR parts 573 and 579.
    FDA has affirmed certain substances as GRAS for their intended use 
in animal food and these are listed in 21 CFR parts 582 and 584. 
Importantly, these lists are not all-inclusive. FDA's Animal Food GRAS 
Notification Program allows individuals and firms to voluntarily notify 
FDA that they have concluded that an animal food substance is GRAS 
under the conditions of its intended use. FDA evaluates the notifier's 
supporting data and responds to the notifier with a letter stating 
whether FDA has questions about the notifier's conclusion. If FDA does 
not have questions, it issues a ``no questions'' letter. A ``no 
questions'' letter is not a legal determination by FDA that the use of 
a substance is GRAS. These notices are posted on FDA's website under 
``Current Animal Food GRAS Notices Inventory,'' along with FDA's letter 
to the notifier regarding its evaluation of the notice.\2\ FDA 
encourages any person who intends to market a food substance on the 
basis of a conclusion of GRAS status to submit a GRAS notice to FDA.
---------------------------------------------------------------------------

    \2\ https://www.fda.gov/food/generally-recognized-safe-gras/gras-notice-inventory.
---------------------------------------------------------------------------

    The Association of American Feed Control Officials (AAFCO) is an 
independent organization with voluntary membership of State and Federal 
regulatory officials in the United States, as well as officials from 
government agencies in other countries, that are responsible for the 
execution of laws and regulations in their jurisdictions pertaining to 
the production, labeling, distribution, use, or sale of animal food 
(including ingredients). FDA is a member of AAFCO and provides 
scientific and technical expertise to the organization.
    Since 1920, AAFCO has maintained the AAFCO Official Publication, 
which contains, among other things, a comprehensive list of animal food 
ingredients, many of which include definitions established through the 
AAFCO ingredient definition request process. In 2007, FDA entered into 
a memorandum of understanding (MOU) with AAFCO that outlines how FDA 
would provide its scientific and technical expertise to AAFCO in 
reviewing requested ingredient definitions. This MOU has been renewed 
and revised several times. The current MOU 225-07-7001 expires on 
October 1, 2024, and will not be renewed. See https://www.fda.gov/animal-veterinary/animal-food-feeds/fda-letter-stakeholders-acknowledgment-expiring-fda-aafco-mou.
    Elsewhere in this issue of the Federal Register, we are publishing 
a notice of availability for a draft guidance for industry #293, ``FDA 
Enforcement Policy for AAFCO-Defined Animal Feed Ingredients.'' This 
draft guidance, when finalized, will communicate FDA's current thinking 
on an enforcement policy regarding certain ingredients listed in 
chapter six of the 2024 AAFCO OP after the expiration of the Agency's 
MOU with AAFCO.
    Elsewhere in this issue of the Federal Register, we also are 
publishing a notice of availability for a draft guidance on our new 
Animal Food Ingredient Consultation (AFIC) process to provide an 
additional way for firms developing animal food ingredients to consult 
with CVM following the expiration of the MOU with AAFCO while FDA 
evaluates the Food Additive Petition and GRAS Notification programs to 
determine if changes are needed to promote their efficiency.

II. Questions for Consideration

    We seek input on the following questions regarding the oversight of 
animal food ingredients:
    1. What do you perceive as barriers and/or benefits to pursuing a 
Food Additive Petition or GRAS Notification?
    2. Are there changes that could make the Food Additive Petition and 
GRAS Notification programs more feasible, such as regulatory changes, 
changes to guidance, or changes to FDA policy or processes?
    3. Is there information that is currently required to be submitted 
in a Food Additive Petition or GRAS Notification that you do not think 
is necessary for evaluating the ingredient?
    4. Is there information that is not currently required to be 
submitted in a Food Additive Petition or GRAS Notification, but should 
be to better enable FDA's evaluation?
    5. What review process for proposed animal food ingredients would 
best enable FDA to review their safety?
    6. If you have submitted a request for an ingredient definition 
through the AAFCO ingredient definition process, what was your reason 
for doing so instead of filing a Food Additive Petition or submitting a 
GRAS Notification with FDA?

    Dated: August 6, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-17779 Filed 8-8-24; 8:45 am]
BILLING CODE 4164-01-P